]>
IRCT20201027049164N2 IRCT 2021-09-16 Kerman University of Medical Sciences Comparative investigation between the effectiveness of Achillea wilhelmsii tablet and group counseling based on acceptance and commitment on Pre Menstrual Syndrome (PMS) symptoms Comparative investigation between the effectiveness of Achillea wilhelmsii tablet and group counseling based on acceptance and commitment on Pre Menstrual Syndrome (PMS) symptoms in students living in the dormitories 2021-09-24 anticipated 264 Complete https://irct.ir/trial/58045 interventional Randomization: Randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Education/Guidance, Randomization description: For simple randomization, the numbers 1 to 135 are assigned to the participants, respectively. Then, using online software to generate random sequences (www.randomizer.org), they will be divided into three groups of 45 will be placed in the counseling group and the yarrow and control receiving group. N/A Premenstrual Syndrome. Intervention 1: Intervention group1: The counseling group will receive 8 sessions of 90-minute counseling based on acceptance and commitment once a week. Intervention 2: Intervention group2: The yarrow group is given yarrow pills at variable doses that follow the estrogen pattern of the menstrual cycle. Thus, at first, the estrogen menstrual cycle is low, and then, like the normal menstrual cycle, when estrogen levels gradually increase, the dose of yarrow pills increases. The maximum dose of the pill is given on the fourteenth day according to the peak estrogen in the normal cycle. Then, as in the normal cycle, when the amount of estrogen decreases, the dose of yarrow tablets decreases, ie the dose of the drug starts from 70 mg, twice a day, and until the fourteenth day, we add 10 mg every day, and on the fourteenth day the maximum dose is 200 mg. We will have 14 days. Intervention 3: Control group: They do not receive any intervention. Undecided - It is not yet known if there will be a plan to make this available Justification or reason for indecision in sharing IPD is The release schedule is not yet known
public zahra pakdel
Kerman University of Medical Sciences, Medical University Campus, Haft-Bagh Highway, Kerman, Iran
kerman Iran (Islamic Republic of) 7616913555 +98 34 3132 5856 zahrapakdel75@gmail.com Kerman University of Medical Sciences scientific Masoumeh Ghazanfarpour
Kerman University of Medical Sciences, Medical University Campus, Haft-Bagh Highway, Kerman, Iran
kerman Iran (Islamic Republic of) 7616913555 +98 34 3132 5856 M.ghazanfarpour@kmu.ac.ir Kerman University of Medical Sciences Iran (Islamic Republic of) All samples should have a menstrual cycle duration of 35-24 days. Being single The age of the samples should be between 18-45 years. Samples with premenstrual syndrome for at least six months and tend to participate in the study. Do not have any mental or physical illness. Do not take any chemical and herbal medicines Do not take birth control pills Have at least one symptom of mental and physical symptoms that should begin 16 days after menstruation 18 years 45 years Female Menstrual period is less than 3 days and more than 8 days Interval of menstrual cycles less than 24 days and more than 35 days Existence of severe stress in the last trimester such as: death of relatives, marriage or surgery Pregnant and lactating women Participating in a simultaneous counseling program N94.3 Premenstrual tension syndrome Treatment - Other Treatment - Drugs N/A Intervention group1: The counseling group will receive 8 sessions of 90-minute counseling based on acceptance and commitment once a week. Intervention group2: The yarrow group is given yarrow pills at variable doses that follow the estrogen pattern of the menstrual cycle. Thus, at first, the estrogen menstrual cycle is low, and then, like the normal menstrual cycle, when estrogen levels gradually increase, the dose of yarrow pills increases. The maximum dose of the pill is given on the fourteenth day according to the peak estrogen in the normal cycle. Then, as in the normal cycle, when the amount of estrogen decreases, the dose of yarrow tablets decreases, ie the dose of the drug starts from 70 mg, twice a day, and until the fourteenth day, we add 10 mg every day, and on the fourteenth day the maximum dose is 200 mg. We will have 14 days Control group: They do not receive any intervention Symptoms of premenstrual syndrome. Timepoint: Beginning of the study (before the start of the intervention) and end of the intervention. Method of measurement: Daily Symptom Report Questionnaire (DSR). Kerman University of Medical Sciences Approved 2021-08-10 Ethics Committee of Kerman University of Medical Sciences Deputy of Research and Technology;ebne-e-Sina St.,Jahad Blvd., Kerman, Iran Kerman Kerman Iran (Islamic Republic of)